newsfilter
← Latest News
GlobeNewswire·

Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

~1.7 million total VOQUEZNA® prescriptions filled to dateRecord Q2 2026 net revenues of $74.3 million, increased 88% vs. Q2 2025 and 27% vs. Q1 2026Q2 operating expenses of $63.1 million, reduced by 33% vs. Q2